Literature DB >> 28268111

Characterization of growth inhibition of oral bacteria by sophorolipid using a microplate-format assay.

Daniel K Y Solaiman1, Richard D Ashby2, Joseph Uknalis2.   

Abstract

Sophorolipid (SL) is a class of glycolipid biosurfactant produced by yeast and has potent antimicrobial activity against many microorganisms. In this paper, a microplate-based method was developed to characterize the growth inhibition by SL on five representative species of caries-causing oral bacteria. Bacterial growth on microplate in the absence and presence of varying concentrations of SL was continuously monitored by recording the absorbance at 600nm of the cultures using a microplate reader. The results showed that SL completely inhibited the growth of the Lactobacilli at ≥1mg/ml and the Streptococci at much lower concentrations of ≥50μg/ml. More importantly, we further defined the mechanism of antimicrobial activity of SL by analyzing the pattern of the cell growth curves. SL at sublethal concentrations (<1mg/ml) is bactericidal towards the Lactobacilli; it lengthens the apparent cell-doubling time (Td) and decreases the final cell density (as indicated by A600nm) in a concentration-dependent manner. Against the oral Streptococci, on the other hand, SL at sublethal concentrations (<50μg/ml) is bacteriostatic; it delays the onset of cell growth in a concentration-dependent fashion, but once the cell growth is commenced there is no noticeable adverse effect on Td and the final A600nm. Scanning electron microscopic (SEM) study of L. acidophilus grown in sublethal concentration of SL reveals extensive structural damage to the cells. S. mutans grown in sublethal level of SL did not show morphological damage to the cells, but numerous protruding structures could be seen on the cell surface. At the respective lethal levels of SL, L. acidophilus cells were lysed (at 1mg/ml SL) and the cell surface structure of S. mutans (at 130μg/ml SL) was extensively deformed. In summary, this paper presents the first report on a detailed analysis of the effects of SL on Lactobacilli and Streptococci important to oral health and hygiene. Published by Elsevier B.V.

Entities:  

Keywords:  Antimicrobial agent; Biosurfactant; Growth-inhibition mechanism; Injured cells; Microplate assay; Tooth decay

Mesh:

Substances:

Year:  2017        PMID: 28268111     DOI: 10.1016/j.mimet.2017.02.012

Source DB:  PubMed          Journal:  J Microbiol Methods        ISSN: 0167-7012            Impact factor:   2.363


  5 in total

Review 1.  Contributions of Glycolipid Biosurfactants and Glycolipid-Modified Materials to Antimicrobial Strategy: A Review.

Authors:  Qin Shu; Hanghang Lou; Tianyu Wei; Xiayu Liu; Qihe Chen
Journal:  Pharmaceutics       Date:  2021-02-06       Impact factor: 6.321

2.  Inhibitory effect of a gel paste containing surface pre-reacted glass-ionomer (S-PRG) filler on the cariogenicity of Streptococcus mutans.

Authors:  Ryota Nomura; Takahiro Kitamura; Saaya Matayoshi; Jumpei Ohata; Yuto Suehiro; Naoki Iwashita; Rena Okawa; Kazuhiko Nakano
Journal:  Sci Rep       Date:  2021-12-06       Impact factor: 4.379

Review 3.  Sophorolipids-Bio-Based Antimicrobial Formulating Agents for Applications in Food and Health.

Authors:  Wei Yan Cho; Jeck Fei Ng; Wei Hsum Yap; Bey Hing Goh
Journal:  Molecules       Date:  2022-08-29       Impact factor: 4.927

4.  Comparison of inhibitory effects and mechanisms of lactonic sophorolipid on different pathogenic bacteria.

Authors:  Xiao-Jing Ma; Tong Wang; Hui-Min Zhang; Jun-Qian Shao; Mei Jiang; Huai Wang; Hui-Xia Zhu; Dong Zhou
Journal:  Front Microbiol       Date:  2022-09-27       Impact factor: 6.064

5.  Antimicrobial effects of sophorolipid in combination with lactic acid against poultry-relevant isolates.

Authors:  Victória Akemi Itakura Silveira; Renata Katsuko Takayama Kobayashi; Admilton Gonçalves de Oliveira Junior; Mario Sérgio Mantovani; Gerson Nakazato; Maria Antonia Pedrine Colabone Celligoi
Journal:  Braz J Microbiol       Date:  2021-06-25       Impact factor: 2.214

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.